Cargando…
Automating Access to Real-World Evidence
INTRODUCTION: Real-world evidence is important in regulatory and funding decisions. Manual data extraction from electronic health records (EHRs) is time-consuming and challenging to maintain. Automated extraction using natural language processing (NLP) and artificial intelligence may facilitate this...
Autores principales: | Gauthier, Marie-Pier, Law, Jennifer H., Le, Lisa W., Li, Janice J.N., Zahir, Sajda, Nirmalakumar, Sharon, Sung, Mike, Pettengell, Christopher, Aviv, Steven, Chu, Ryan, Sacher, Adrian, Liu, Geoffrey, Bradbury, Penelope, Shepherd, Frances A., Leighl, Natasha B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201015/ https://www.ncbi.nlm.nih.gov/pubmed/35719866 http://dx.doi.org/10.1016/j.jtocrr.2022.100340 |
Ejemplares similares
-
The effect of prior cancer on non‐small cell lung cancer trial eligibility
por: Herman, Michael, et al.
Publicado: (2021) -
Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection
por: Sung, Mike R., et al.
Publicado: (2021) -
Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
por: Sung, Mike, et al.
Publicado: (2020) -
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer
por: Kuang, Shelley, et al.
Publicado: (2022) -
Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies
por: Lau, Sally C.M., et al.
Publicado: (2023)